Omega Funds
Overview
Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
Investment Focus
- Strong management teams
- Innovative products
- Potential for significant impact in therapeutic areas
Portfolio Companies
Get the full list of 54,000+ investors
Omega Funds and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Omega Funds
What sectors does Omega Funds invest in?
Omega Funds invests in Healthcare, Life Sciences, Medical Devices, Biotechnology, Oncology and Precision Medicine, and is based in Boston, Massachusetts, United States. Omega Funds is listed as a vc in the ConnectSafely investor database.
What stage does Omega Funds invest at?
Omega Funds backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 10M - 50M.
Which regions does Omega Funds invest in?
Omega Funds invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has Omega Funds invested in?
Omega Funds's portfolio includes Beam Therapeutics, Bluebird Bio, Moderna, Alnylam Pharmaceuticals, Editas Medicine, Sarepta Therapeutics, Intellia Therapeutics and CRISPR Therapeutics.
How do I contact Omega Funds?
Omega Funds's contact details — including work email and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
